WorkforceQA Background Screening Services – Streamline all your employee screening needs on one seamless platform to simplify ordering, improve visibility, and reduce turnaround time.
More Information
- This event has passed.
WEBINAR: HHS Proposed Revisions to Drug Testing Programs
September 13, 2022 @ 3:00 pm - 4:00 pm
The Department of Health and Human Services (HHS) published proposed changes to the Mandatory Guidelines for Federal Workplace Drug Testing Programs using Oral Fluid (OFMG) and Urine (UrMG). These Guidelines apply to 1.5 million federal employees in safety-sensitive or security-critical positions.
Tuesday / September 13th / 3:00 PM EST
Join WFQA’s Dr. Donna Smith, Regulatory Compliance Director, as she discusses the following changes that are being proposed to the OFMG to catch up with current drug testing practice and technical advances:
-
- Establish a Process to Publish the HHS Authorized Drug Testing Panel
- Revise the Definition of a Substituted Specimen
- Authorized Biomarker Testing Panel
- Oral fluid collection procedures
- Medical Review Officer (MRO) Verification Process for Positive Codeine and Morphine Specimens
REGISTER HERE
PRESENTED BY:
Dr. Donna Smith, WFQA’s Regulatory Compliance Director, has over 30 years of experience and expertise in regulatory compliance. She is a nationally recognized expert in the areas of Federal drug testing regulations, drug and alcohol testing procedures, drug and alcohol abuse awareness training for employees and managers, medical review officer (MRO) procedures, drug-free workplace policy and procedures, and substance abuse prevention and rehabilitation.
Federal Register Proposed Rule by the Health and Human Services Department